GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
25 hedge funds and large institutions have $820K invested in Aevi Genomic Medicine Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$65.5K | |
| 2 | +$44.5K | |
| 3 | +$21.8K | |
| 4 |
VF
Virtu Financial
New York
|
+$4.89K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.93K |
Top Sellers
| 1 | -$15K | |
| 2 | -$6K | |
| 3 | -$4.18K | |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$2K |
| 5 |
KCPG
Kavar Capital Partners Group
Leawood,
Kansas
|
-$1K |